PepGen Ltd (PEPG)
Healthcare
Biotechnology
1.80 $
-1.1%
vs. previous close
Closing price · As of: 31. Jul 2026
Who owns PepGen Ltd (PEPG)? This page shows the largest institutions and funds, the ownership structure and the latest insider transactions. 52.1% of the shares are freely tradable; institutional investors hold 90.2%.
Ownership Structure
Institutional ownership
Share of the stock held by institutional investors (funds, banks, insurers) according to regulatory filings.
90.2%
Insiders
Share of the stock held by the executives, founders and major shareholders of the company itself.
0.2%
Float
Share of stock freely tradable on the market — not locked up in the hands of founders, insiders, or major shareholders.
52.1%
Short % of float
Shares sold short as a percentage of the freely tradable float — high values signal many bets on falling prices.
7.9%
Shares Outstanding
Total number of shares issued. Price times share count gives market cap.
69Mio.
Largest Shareholders
Institutions
| Name | Stake (%) | Shares | Change (%) | Date |
|---|---|---|---|---|
| RA Capital Management, LLC | 29.01 | 20,064,545 | +0.0 | 03/31/2026 |
| COMMODORE CAPITAL LP | 6.47 | 4,475,000 | +31.6 | 03/31/2026 |
| Viking Global Investors LP | 5.03 | 3,482,434 | +0.0 | 03/31/2026 |
| LAURION CAPITAL MANAGEMENT LP | 3.98 | 2,750,855 | +34.0 | 03/31/2026 |
| Vivo Capital, LLC | 3.36 | 2,325,000 | +0.0 | 03/31/2026 |
| Vanguard Group Inc | 3.20 | 2,212,834 | +25.1 | 12/31/2025 |
| Millennium Management LLC | 3.01 | 2,079,143 | +950.4 | 03/31/2026 |
| Vanguard Capital Management, LLC | 2.80 | 1,937,699 | +0.0 | 03/31/2026 |
| Awm Investment Company Inc | 2.65 | 1,830,925 | +40.8 | 03/31/2026 |
| Kalehua Capital Management LLC | 2.50 | 1,729,961 | +0.0 | 03/31/2026 |
Largest reported positions according to regulatory filings; stake as a percentage of shares outstanding, change versus the previous filing. Source: fundamentals data.
Data as of: July 31, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.